MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SOLITARY PLASMACYTOMA, Hematology/Oncology Clinics of North America, vol.11, issue.1, pp.71-87, 1997. ,
DOI : 10.1016/S0889-8588(05)70416-0
Les gammapathies monoclonales en médecine ambulatoire : étude prospective de 300 électrophoreses des protéines demandées de facon systématique par des omnipraticiens des alpes-maritimes chez des patients de plus de 60 ans, Thèse Nice, 1992. ,
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma. IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management Leukemia, pp.1121-1127, 2010. ,
Incipient myelomatosis or essential hyperglobulinemia with fibrinogenopenia -a new syndrome ? Acts Med Scand, pp.216-247, 1944. ,
Monoclonal gammopathy of undetermined significance, The American Journal of Medicine, vol.64, issue.5, pp.814-840, 1978. ,
DOI : 10.1016/0002-9343(78)90522-3
URL : https://hal.archives-ouvertes.fr/hal-00945713
Microbiologie et immunologie On line, 2016. ,
Gammapathies monoclonales de signification indéterminée. EMC - Hématologie, 2012. ,
Prevalence of Monoclonal Gammopathy of Undetermined Significance, New England Journal of Medicine, vol.354, issue.13, pp.1362-1369, 2006. ,
DOI : 10.1056/NEJMoa054494
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance, New England Journal of Medicine, vol.346, issue.8, pp.564-569, 2002. ,
DOI : 10.1056/NEJMoa01133202
Criteria for the clasification of monoclonal gammopathies, multiple myeloma and related disorders, Br J haematol, vol.121, issue.121, pp.749-57, 2003. ,
Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entities in the Presence of Evolving Scientific Evidence, Mayo Clinic Proceedings, vol.85, issue.10, pp.945-948, 2010. ,
DOI : 10.4065/mcp.2010.0520
Fracture Risk in Monoclonal Gammopathy of Undetermined Significance, Journal of Bone and Mineral Research, vol.11, issue.Suppl 2, pp.25-30, 2004. ,
DOI : 10.1359/jbmr.0301212
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study, Blood, vol.115, issue.24, pp.4991-4998, 2010. ,
DOI : 10.1182/blood-2009-11-252072
Prevalence of monoclonal protein in peripheral neuropathy, Neurology, vol.31, issue.11, pp.1480-1483, 1991. ,
DOI : 10.1212/WNL.31.11.1480
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma, New England Journal of Medicine, vol.356, issue.25, pp.2582-90, 2007. ,
DOI : 10.1056/NEJMoa070389
International Myéloma Working group updated criteria for the diagnosis of multiple myeloma. The Lancet Oncology, pp.538-586, 2014. ,
Monoclonal gammopathy of renal significance (MGRS) : when MGUS is no longer undertermined or insignificant, Blood. 2012, vol.120, issue.22, pp.4292-4297 ,
Leucémie à plasmocytes, Hématologie, vol.11, issue.3, pp.217-225, 2005. ,
Myélome et plasmocytome : aspects radiologiques des localisations extra-osseuses. . SFRNET. [Online] [Cited: Juillet 28, pp.5-8, 2005. ,
Dosage sérique des chaînes légères, pp.6-7, 2006. ,
Elaboration et validation d'un référentiel de prescription et de décision en cas de pic monoclonal. Exercer, pp.68-74, 2011. ,
Tumeur maligne, affection maligne du tissu, lymphatique ou hématopoïétique : Myélome Multiple. [Online] Décembre 2010. [Cited: 06 2016, 01 ,
Screening panels for monoclonal gammopathies : time to change, Clin Biochem Rev, vol.30, pp.105-111, 2009. ,
Screening Panels for Detection of Monoclonal Gammopathies, Clinical Chemistry, vol.55, issue.8, pp.1714-1720, 2009. ,
DOI : 10.1373/clinchem.2009.126664
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management, Leukemia, vol.102, issue.6, pp.1121-1127, 2010. ,
DOI : 10.1182/blood-2007-08-108357
Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance, British Journal of Haematology, vol.64, issue.3, pp.391-394, 1992. ,
DOI : 10.2307/2529177
Prise en charge d'une découverte d'une gammpathie monoclonale en ville par le médecin généraliste, Thèse Paris VI, 2013. ,
Chaînes légères libres d'immunoglobulines. [Online] [Cited: 07 07, 2016. ,
Monoclonal gammopathy of undertermined significance (MGUS) and Smoldering (asymptomatic) multiple myeloma : IMWG consensus perspective risk factors for progression and guidelines for monitoring and management. leukemia, pp.1121-1128, 2010. ,